These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19399381)

  • 1. Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives.
    Sander D; Kearney MT
    J Neurol; 2009 Oct; 256(10):1603-19. PubMed ID: 19399381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and prevention among patients with stroke: a study of 36,844 patients hospitalized in France].
    Tuppin P; Moysan V; de Peretti C; Schnitzler A; Fery-Lemonnier E; Woimant F
    Rev Neurol (Paris); 2013 Feb; 169(2):126-35. PubMed ID: 22749335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The management of cerebrovascular events].
    Sène Diouf F; Ndiaye MM
    Dakar Med; 2008; 53(1):7-19. PubMed ID: 19102112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study.
    Liu CH; Lee TH; Lin YS; Sung PS; Wei YC; Li YR
    Cardiovasc Diabetol; 2020 Jan; 19(1):2. PubMed ID: 31910836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice.
    Patoulias D; Stavropoulos K; Imprialos K; Athyros V; Doumas M; Karagiannis A
    Curr Vasc Pharmacol; 2020; 18(2):125-138. PubMed ID: 32013815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?
    Saposnik G; Goodman SG; Leiter LA; Yan RT; Fitchett DH; Bayer NH; Casanova A; Langer A; Yan AT; ; ;
    Stroke; 2009 Apr; 40(4):1417-24. PubMed ID: 19213947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of cardiovascular disease in type 2 diabetic patients].
    Yokota C
    Nihon Rinsho; 2003 Jul; 61(7):1161-6. PubMed ID: 12877078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New perspectives on the pharmacotherapy of ischemic stroke.
    Bradberry JC; Fagan SC; Gray DR; Moon YS
    J Am Pharm Assoc (2003); 2004; 44(2 Suppl 1):S46-56; quiz S56-7. PubMed ID: 15095935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-up.
    Jansson SP; Svärdsudd K; Andersson DK
    Diabet Med; 2014 Sep; 31(9):1055-63. PubMed ID: 24894815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cardiovascular events in elderly people.
    Andrawes WF; Bussy C; Belmin J
    Drugs Aging; 2005; 22(10):859-76. PubMed ID: 16245959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
    Lan J; Zhao Y; Dong F; Yan Z; Zheng W; Fan J; Sun G
    J Ethnopharmacol; 2015 Feb; 161():69-81. PubMed ID: 25498346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
    Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
    Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapies.
    Zoungas S; Patel A
    Ann N Y Acad Sci; 2010 Nov; 1212():29-40. PubMed ID: 21091713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in clinical neurosciences: pharmacotherapies for the secondary prevention of stroke.
    Hackam DG; Kapral MK
    Can J Neurol Sci; 2004 Aug; 31(3):295-303. PubMed ID: 15376471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent blood pressure, glycemic and lipid control for the prevention of vascular complications of type II diabetes mellitus: a long overdue objective?
    Athyros VG; Mitsiou EK; Tziomalos K; Karagiannis A; Mikhailidis DP
    Curr Vasc Pharmacol; 2010 Jan; 8(1):1-4. PubMed ID: 20394107
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies.
    Avogaro A; Barillà F; Cavalot F; Consoli A; Federici M; Mancone M; Paolillo S; Pedrinelli R; Perseghin G; Perrone Filardi P; Scicali R; Sinagra G; Spaccarotella C; Indolfi C; Purrello F
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1671-1690. PubMed ID: 33994263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prestroke treatment of stroke risk factors: A cross-sectional survey in central Nigeria.
    Alkali NH; Bwala SA; Dunga JA; Watila MM; Jibrin YB; Tahir A
    Ann Afr Med; 2016; 15(3):120-5. PubMed ID: 27549416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stroke is not equal to stroke. Keep track of the causes].
    Stiefelhagen P
    MMW Fortschr Med; 2003; 145 Suppl 1():4-5. PubMed ID: 12958794
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological strategies to reduce cardiovascular risk in type 2 diabetes mellitus: an update.
    Hovens MM; Tamsma JT; Beishuizen ED; Huisman MV
    Drugs; 2005; 65(4):433-45. PubMed ID: 15733008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-Related Differences in the Control of Cardiovascular Risk Factors in Primary Care for Elderly Patients With Type 2 Diabetes: A Cohort Study.
    Al-Salameh A; Bucher S; Bauduceau B; Benattar-Zibi L; Berrut G; Bertin P; Corruble E; Danchin N; Derumeaux G; Doucet J; Falissard B; Forette F; Hanon O; Ourabah R; Pasquier F; Pinget M; Ringa V; Becquemont L
    Can J Diabetes; 2018 Aug; 42(4):365-371.e2. PubMed ID: 29037572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.